Proliferative Endometrium: Understanding Your Pathology Report

Section Editor: Kianoosh Keyhanian MD FRCPC
September 1, 2026

Proliferative endometrium describes the normal appearance of the lining of the uterus during the first half of the menstrual cycle. The lining is called the endometrium. “Proliferative” means growing, and it refers to the rebuilding of the lining that happens after a period ends.

This is a normal finding, not a disease. It is not cancer, and it is not precancerous. If proliferative endometrium is the only thing described in your report, the pathologist examined the lining and found it normal.

What the finding means for you depends on when in your cycle the sample was taken and on whether you have gone through menopause. This article will help you understand what the term means on your pathology report and how to read it in your own situation.

Why was my endometrium sampled?

The lining of the uterus is sampled by an endometrial biopsy, a brief clinic procedure using a thin flexible tube, or by a dilation and curettage. It may also be examined in a uterus removed at surgery. Common reasons for sampling include:

Abnormal uterine bleeding — Heavy, prolonged, or irregular bleeding, or bleeding between periods.
Bleeding after menopause — Any bleeding after menopause is investigated, whatever the eventual cause.
Difficulty becoming pregnant — The lining is examined to see whether it is responding to hormones as expected.
Follow-up of a previous finding — Confirming that endometrial hyperplasia has resolved after treatment.
Investigation of a polyp — An endometrial polyp or an endocervical polyp seen on imaging or at hysteroscopy.
Abnormal cells on a Pap test — Sometimes glandular cells on a cervical sample prompt examination of the lining.

What does proliferative endometrium look like under the microscope?

Proliferative endometrium is the lining of the uterus in its growing phase, under the influence of estrogen and before ovulation. Under the microscope, the pathologist looks for the following features.

Straight, evenly spaced glands — The endometrial glands are tube-shaped, similar in size, and spread evenly through the supporting tissue. Even spacing is what separates a normal lining from the crowded pattern of hyperplasia.
Tall lining cells — The cells forming the glands are tall and column-shaped, with their nuclei sitting at different levels.
Dividing cells — Cells caught in the act of dividing, called mitotic figures, are present in both the glands and the supporting tissue. Their presence here is normal, because the lining is actively rebuilding. They do not indicate a tumor.
Dense supporting tissue — The tissue between the glands is compact and cellular.
No secretory changes — The glands contain no secretions, and the cells hold no clear droplets. Those changes appear only after ovulation, in the second half of the cycle.

What does this finding mean in my situation?

Proliferative endometrium is always a normal appearance, but whether it is the expected appearance depends on your circumstances.

Before menopause, sampled in the first half of the cycle — Exactly what should be found. Nothing further follows from it.
Before menopause, sampled in the second half of the cycle — The lining should have changed to a secretory appearance after ovulation. A proliferative lining at that point suggests ovulation did not occur in that cycle. This matters if you are trying to become pregnant, or if you have irregular bleeding.
After menopause — This is the situation worth asking about. The ovaries stop producing estrogen at menopause, so a lining that is still growing means estrogen is reaching it from another source.
While taking hormonal treatment — The report describes how your lining is responding, which can help your doctor judge whether a treatment is working.

After menopause, the usual sources of estrogen are body fat, which converts other hormones into estrogen, and hormone therapy containing estrogen. Tamoxifen, taken for breast cancer, acts like estrogen in the uterus. Uncommonly, an estrogen-producing ovarian tumor such as a thecoma is responsible. None of these is an emergency, but each is worth identifying.

What does “negative for hyperplasia and malignancy” mean?

This phrase appears frequently alongside proliferative endometrium and is worth translating. It means the pathologist looked specifically for two things and found neither.

Hyperplasia — A lining in which the glands have become crowded together. Endometrial hyperplasia is noncancerous but is treated and followed.
Malignancy — Cancer of the lining of the uterus, most often endometrioid carcinoma.

One limitation is worth knowing. A biopsy samples part of the lining rather than all of it, so a small or focal abnormality such as a polyp can be missed. If your bleeding continues despite a normal result, tell your doctor, because further investigation may be warranted.

How is this different from other descriptions of the endometrium?

Pathologists use several terms to describe the lining, and most describe normal states rather than disease. Your report may use any of the following.

Proliferative endometrium — Normal, first half of the cycle. Evenly spaced, straight glands.
Secretory endometrium — Normal, second half of the cycle, after ovulation. Secretory endometrium shows glands that have become coiled and are producing secretions.
Atrophic endometrium — A thin, inactive lining, normal after menopause. Atrophic endometrium is the expected finding at that stage of life.
Disordered proliferative endometrium — Glands that are irregular in shape and unevenly spaced, but not crowded. Disordered proliferative endometrium reflects estrogen acting without progesterone. It is not precancerous.
Endometrial hyperplasia — Glands that have become genuinely crowded. This is treated and followed.

What other findings may be described in the report?

Proliferative endometrium is often reported alongside other findings from the same sample.

Endometrial polyp — A benign overgrowth of the lining and a common cause of abnormal bleeding.
Breakdown and bleeding — Areas where the lining is shedding, which may explain the symptoms.
Chronic inflammation — If plasma cells are present, the report may also diagnose chronic endometritis.
Metaplasia — Areas where the lining cells take on a different but still normal appearance. This is common and not precancerous.
Sample adequacy — The report may say the sample was scant, fragmented, or insufficient for evaluation. This is common with a thin lining and may mean the sample needs to be repeated.

What happens next?

A report of proliferative endometrium alone requires no treatment or follow-up. What happens next depends on why the sample was taken and whether your symptoms have settled. Points your doctor may raise include:

Looking elsewhere for a cause — If you were investigated for bleeding and the lining is normal, the bleeding has another explanation. Fibroids, polyps, adenomyosis, and hormonal causes are all possibilities.
Cycles without ovulation — If the finding suggests you are not ovulating regularly, your doctor may investigate that, particularly if you are trying to conceive.
Finding the estrogen source after menopause — Reviewing hormone therapy, body weight, or, uncommonly, imaging of the ovaries.
Repeating the sample — If the sample was scant or the bleeding continues, your doctor may arrange a repeat biopsy or a hysteroscopy.

Questions to ask your doctor

Is this a normal finding for where I am in my cycle?
I have gone through menopause. Should a proliferative lining be there?
If so, where might the estrogen be coming from?
Does this finding explain my bleeding, or should we look elsewhere?
Does this suggest I am not ovulating?
Was the sample adequate, or should it be repeated?
Did the report mention a polyp or any other finding?
Does my report say negative for hyperplasia and malignancy?
Do I need any treatment or follow-up?
Should my hormone therapy be reviewed?
What symptoms should prompt me to contact you?